Expanded Access Program:Lenalidomide With or Without Dexamethasone In Previously Treated Subjects With Multiple Myeloma

Clinical trial NCT00179647 · COMPLETED

Trial details

NCT number: NCT00179647
Sponsor: Celgene Corporation
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2005-09-01
Primary completion: 2008-12-01
Enrollment: 1913

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.